ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,648.55
0.25%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX
  6. Brumby Res Fpo (BMY)

  7. Brumby Res Fpo (BMY) Noticias

BMY

Brumby Resources (BMY)

Brumby Res Fpo
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:ASX:BMY
FechaHoraFuenteTítuloSímboloCompañía
16/10/200915:56Dow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
16/10/200908:29Dow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
05/10/200910:04Dow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingNYSE:BMYBristol-Myers Squibb Co.
05/10/200909:23Dow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationNYSE:BMYBristol-Myers Squibb Co.
02/10/200904:45Dow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinNYSE:BMYBristol-Myers Squibb Co.
01/10/200915:48Dow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyNYSE:BMYBristol-Myers Squibb Co.
29/09/200915:14Dow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonNYSE:BMYBristol-Myers Squibb Co.
23/09/200909:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNYSE:BMYBristol-Myers Squibb Co.
23/09/200908:22Dow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherNYSE:BMYBristol-Myers Squibb Co.
23/09/200904:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNYSE:BMYBristol-Myers Squibb Co.
21/09/200913:52Dow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressNYSE:BMYBristol-Myers Squibb Co.
21/09/200913:28Dow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeNYSE:BMYBristol-Myers Squibb Co.
17/09/200908:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNYSE:BMYBristol-Myers Squibb Co.
15/09/200923:29Dow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionNYSE:BMYBristol-Myers Squibb Co.
15/09/200922:00Dow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaNYSE:BMYBristol-Myers Squibb Co.
08/09/200916:11Dow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200912:08Dow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200910:40Dow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
31/08/200905:30Dow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixNYSE:BMYBristol-Myers Squibb Co.
30/08/200901:30Dow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyNYSE:BMYBristol-Myers Squibb Co.
28/08/200913:59Dow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueNYSE:BMYBristol-Myers Squibb Co.
28/08/200910:46Dow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
28/08/200905:57Dow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
25/08/200916:12Dow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
25/08/200915:30Dow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
20/08/200916:42Dow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineNYSE:BMYBristol-Myers Squibb Co.
18/08/200918:53Dow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsNYSE:BMYBristol-Myers Squibb Co.
18/08/200915:51Dow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200912:06Dow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200910:41Dow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
 Showing the most relevant articles for your search:ASX:BMY

Su Consulta Reciente

BIT
UC6TH2
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados